The publication aims to compare the risk of below the knee amputation with SGLT2 inhibitors versus DPP-4 inhibitors among people with type 2 diabetes.
Citation
Oriana Hoi Yun Yu, Sophie Dell’Aniello, Baiju R. Shah, Vanessa C. Brunetti, Jean-Marc Daigle, Michael Fralick, Antonios Douros, Nianping Hu, Silvia Alessi-Severini, Anat Fisher, Shawn C. Bugden, Paul E. Ronksley, Kristian B. Filion, Pierre Ernst, Lisa M. Lix. Diabetes Care Aug 2020, dc200267; DOI: 10.2337/dc20-0267